Meta-analysis was used to calculate maternal serum marker distribution parameters for Down syndrome risk estimation in the first trimester. Data from 44 series were combined: relating to pregnancy associated plasma protein (PAPP)-A in 18, free human chorionic gonadotrophin (hCG) in 17, -fetoprotein
LETTER TO THE EDITOR. ULTRASOUND DATING IN FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROME
✍ Scribed by A. BORRELL; M. T. FARRÉ; D. COSTA; A. FORTUNY
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 125 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
✦ Synopsis
Ultrasound dating in first-trimester biochemical screening for Down syndrome
We have read with interest the article by Macintosh ef al. (1995) which describes the effects of ultrasound estimation of gestational age on the performance of first-trimester biochemical screening for fetal aneuploidy.
In this study, the crown-rump length (CRL) measurement had the effect of crediting aneuploid fetuses a mean of 2.5 days less in estimation of gestational age than expected by the last menstrual period (LMP). Consequently, the maternal serum PAPP-A (MS-PAPP-A) value expressed as multiples of the mean for euploid pregnancies resulted in a smaller reduction than the value derived from gestational age based on dates. Therefore, ultrasound dating would lead to a significant underdetection for aneuploidy. In relation specifically to Down syndrome, the detection rate by means of PAPP-A was not significantly reduced (3 per cent) when ultrasound rather than dates was used to estimate gestational age.
In our unit, we have studied 1637 consecutive first-trimester pregnancies (9-1 3 weeks) undergoing transcervical chorionic villus sampling,
📜 SIMILAR VOLUMES
Data on pregnancies with and without Down's syndrome between 10 and 14 weeks of pregnancy were used to determine the performance of combined ultrasound and biochemical markers in prenatal screening for Down's syndrome. We used three datasets: one published by on nuchal translucency measurement in 8
We have carried out a large retrospective study of -fetoprotein (AFP), free-human chorionic gonadotrophin (hCG) and pregnancy-associated plasma protein (PAPP-A) in the first trimester of pregnancy. Unlike other studies all women had routine ultrasound dating, carried out during a nuchal translucency